Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib
Por um escritor misterioso
Descrição
Structure-Function Relationships of Covalent and Non-Covalent BTK Inhibitors. - Abstract - Europe PMC
A steady-state algebraic model for the time course of covalent enzyme inhibition
BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies, Journal of Hematology & Oncology
Ibrutinib Inhibits Platelet Integrin αIIbβ3 Outside-In Signaling and Thrombus Stability But Not Adhesion to Collagen
Haematologica, Volume 108, Issue 1 by Haematologica - Issuu
A guide to enzyme kinetics in early drug discovery - Srinivasan - 2023 - The FEBS Journal - Wiley Online Library
Frontiers Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia
Pharmaceuticals, Free Full-Text
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two – topic of research paper in Biological sciences. Download scholarly article PDF and read for
Melissa Hopper - Immunology Doctoral Candidate - Mayo Clinic Graduate School of Biomedical Sciences
de
por adulto (o preço varia de acordo com o tamanho do grupo)
